October 31, 2014 17:11 (IST)
Drug firm Pfizer Inc on Friday said the Bombay High Court has approved the amalgamation of Wyeth Ltd with the company.
October 29, 2014 23:49 (IST)
The National Pharmaceutical Pricing Authority (NPPA) has revised the price of Dettol antiseptic liquid formulations under the directions of the Delhi High Court.
October 28, 2014 22:19 (IST)
Dr Reddy's Laboratories said on Tuesday that it has launched a generic version of Wyeth's Rapamune tablets, an immunosuppressant, in the US market.
October 28, 2014 21:30 (IST)
Ranbaxy Laboratories still has exclusive rights to the launch of AstraZeneca's heartburn drug Nexium in the United States, it said on Tuesday, despite regulatory concern over the manufacturing process.
October 24, 2014 20:18 (IST)
US drug maker Pfizer is to continue buying back stock, with the board authorising a new $11-billion share repurchase plan, deflating expectations that it will make a new bid for AstraZeneca.
October 21, 2014 15:00 (IST)
Looking to bolster its overseas presence, drug major Lupin is scouting for acquisition opportunities in the US market, especially in inhalers and injectables segments.
October 21, 2014 14:42 (IST)
Natco Pharma on Tuesday said its marketing partner in the US, Breckenridge Pharmaceutical Inc, has received a tentative approval from the United States Food and Drug Administration (FDA) for a generic tablet used for improving wakefulness in adults. Shares rose as much as 6.6 per cent during the day.
October 15, 2014 20:12 (IST)
Elder Pharmaceuticals on Wednesday said it has entered into fast-growing Rs 600-crore Indian mouthwash category in the oral care segment where the company is eyeing 5-7 per cent share in the next few years.
October 13, 2014 20:16 (IST)
Drug major Novartis has been slapped with a Rs 300 crore penalty by the National Pharmaceutical Pricing Authority (NPPA) for overcharging consumers on sale of Voveran, its best-selling painkiller.
October 12, 2014 18:24 (IST)
For the July-September period, we expect a robust growth of 18 per cent in revenues, EBITDA 22 per cent and earnings 18 per cent for our coverage universe, driven by ramp-up in the US and steady growth in India due to price hikes for certain products," Edelweiss Securities said in its report here.
October 09, 2014 22:49 (IST)
The Centre's decision to decontrol prices of 108 cardiac and diabetes drugs was on Thsrday challenged before the Supreme Court which agreed to hear the case "as soon as possible".
October 09, 2014 22:38 (IST)
Indian pharmaceutical companies need to focus on the Latin American markets namely Brazil and Mexico, British brokerage firm Barclays has said.
October 08, 2014 22:59 (IST)
India's pharma majors Dr Reddy's and Sun Pharma are among 14 drug makers which are being probed by the US Congress over price escalation of generic drugs.
October 07, 2014 16:18 (IST)
Cipla, which will own 75 per cent stake in the plant being set up in partnership with its local distributor, will invest about Rs 225 crore ($36.65 million) over three years on areas including machinery and equipment for the facility.
October 05, 2014 19:37 (IST)
India's over the counter (OTC) drug market is expected to grow to $6.6 billion by 2016 with pharmaceutical companies and chemists increasing their presence in the rural market.
October 04, 2014 17:14 (IST)
Drug major Cipla has signed an agreement with its Iranian distributor for setting up a manufacturing unit in that country.
October 01, 2014 20:53 (IST)
Drug firm Ranbaxy Laboratories on Wednesday launched a capsule used for treatment of severe acne in the US.
October 01, 2014 11:00 (IST)
Analysts say Apollo would benefit by potentially attracting more patients to its main hospitals.
September 30, 2014 22:58 (IST)
The Delhi High Court on Tuesday asked the National Pharmaceutical Pricing Authority (NPPA) to show the manner in which it is exercising its power to cap prices of non-scheduled drugs in view of the recent withdrawal of the guidelines issued for the purpose.
September 29, 2014 22:50 (IST)
Drug maker Sun Pharma has said that it will take a "few years" for it to realise the benefits of its $4-billion takeover of Ranbaxy, terming the deal as a "complex and large acquisition".